The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care

Recruiting Observational Study
Cardiogenic Shock
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Cardiogenic shock is a frequent reason for hospitalization in critical care units, with high mortality (50%). Several French registries have been created to improve knowledge of the prognostic factors of cardiogenic shock. In recent years, temporary mechanical circulatory support has become more important in cardiogenic shock. The monitoring of catecholamines is also performed with a global score:…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients hospitalized in ICU for cardiogenic shock * Patient with cardiogenic shock as defined by the FRENSCHOCK2 study criteria Exclusion Criteria: * Patient with cardiogenic shock in the context of septic shock and hemorrhagic shock
Contacts

Christophe Beyls, MD

03 22 08 78 66

beyls.christophe@chu-amiens.fr

CONTACT